vs

Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and Mawson Infrastructure Group Inc. (MIGI). Click either name above to swap in a different company.

Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $3.2M, roughly 1.2× Mawson Infrastructure Group Inc.). On growth, Opus Genetics, Inc. posted the faster year-over-year revenue change (-10.2% vs -78.5%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs -58.5%).

Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.

Mawson Infrastructure Group Inc. is a global digital infrastructure provider that operates sustainable, energy-efficient data centers and specialized hosting solutions for blockchain and digital asset operations. Its core segments include cryptocurrency mining, colocation services, and low-carbon infrastructure development, with primary operational footprints across North America and Australia.

IRD vs MIGI — Head-to-Head

Bigger by revenue
IRD
IRD
1.2× larger
IRD
$3.9M
$3.2M
MIGI
Growing faster (revenue YoY)
IRD
IRD
+68.4% gap
IRD
-10.2%
-78.5%
MIGI
Faster 2-yr revenue CAGR
IRD
IRD
Annualised
IRD
50.3%
-58.5%
MIGI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRD
IRD
MIGI
MIGI
Revenue
$3.9M
$3.2M
Net Profit
Gross Margin
Operating Margin
Net Margin
Revenue YoY
-10.2%
-78.5%
Net Profit YoY
53.0%
-246.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRD
IRD
MIGI
MIGI
Q4 25
$3.9M
$3.2M
Q3 25
$3.1M
$13.2M
Q2 25
$2.9M
$9.5M
Q1 25
$4.4M
$13.8M
Q4 24
$4.3M
$15.1M
Q3 24
$3.9M
$12.3M
Q2 24
$1.1M
$13.1M
Q1 24
$1.7M
$18.8M
Net Profit
IRD
IRD
MIGI
MIGI
Q4 25
Q3 25
$-17.5M
$327.7K
Q2 25
$-7.4M
$-8.0M
Q1 25
$-8.2M
$-310.9K
Q4 24
$-4.5M
Q3 24
$-7.5M
$-12.2M
Q2 24
$-7.8M
$-9.6M
Q1 24
$-7.1M
$-19.8M
Gross Margin
IRD
IRD
MIGI
MIGI
Q4 25
Q3 25
65.0%
Q2 25
41.3%
Q1 25
42.9%
Q4 24
30.9%
Q3 24
35.1%
Q2 24
32.9%
Q1 24
37.2%
Operating Margin
IRD
IRD
MIGI
MIGI
Q4 25
Q3 25
-269.9%
12.0%
Q2 25
-309.0%
-68.9%
Q1 25
-227.2%
4.2%
Q4 24
-35.2%
Q3 24
-207.1%
-92.6%
Q2 24
-748.9%
-51.5%
Q1 24
-450.5%
-41.0%
Net Margin
IRD
IRD
MIGI
MIGI
Q4 25
Q3 25
-566.9%
2.5%
Q2 25
-257.5%
-84.1%
Q1 25
-187.5%
-2.3%
Q4 24
-30.0%
Q3 24
-194.6%
-99.3%
Q2 24
-698.3%
-73.4%
Q1 24
-415.3%
-105.3%
EPS (diluted)
IRD
IRD
MIGI
MIGI
Q4 25
Q3 25
$-0.25
$0.01
Q2 25
$-0.12
$-0.40
Q1 25
$-0.24
$-0.02
Q4 24
$-49.35
Q3 24
$-0.29
$-0.66
Q2 24
$-0.30
$-0.55
Q1 24
$-0.29
$-1.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRD
IRD
MIGI
MIGI
Cash + ST InvestmentsLiquidity on hand
$45.1M
$13.3M
Total DebtLower is stronger
$25.2M
Stockholders' EquityBook value
$15.3M
$-3.1M
Total Assets
$50.2M
$57.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRD
IRD
MIGI
MIGI
Q4 25
$45.1M
$13.3M
Q3 25
$30.8M
$2.3M
Q2 25
$32.4M
$3.2M
Q1 25
$41.8M
$5.5M
Q4 24
$30.3M
$6.1M
Q3 24
$36.6M
$5.8M
Q2 24
$41.4M
$6.8M
Q1 24
$47.2M
$6.4M
Total Debt
IRD
IRD
MIGI
MIGI
Q4 25
$25.2M
Q3 25
Q2 25
Q1 25
Q4 24
$20.9M
Q3 24
Q2 24
$393.2K
Q1 24
$41.5K
Stockholders' Equity
IRD
IRD
MIGI
MIGI
Q4 25
$15.3M
$-3.1M
Q3 25
$6.0M
$-9.4M
Q2 25
$17.5M
$-8.3M
Q1 25
$5.1M
$-1.4M
Q4 24
$6.7M
$-3.2M
Q3 24
$34.3M
$-1.6M
Q2 24
$40.6M
$4.4M
Q1 24
$46.1M
$13.0M
Total Assets
IRD
IRD
MIGI
MIGI
Q4 25
$50.2M
$57.4M
Q3 25
$36.1M
$52.0M
Q2 25
$38.7M
$52.7M
Q1 25
$48.2M
$57.9M
Q4 24
$36.9M
$61.4M
Q3 24
$40.4M
$60.8M
Q2 24
$44.8M
$65.6M
Q1 24
$51.8M
$67.7M
Debt / Equity
IRD
IRD
MIGI
MIGI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.09×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRD
IRD
MIGI
MIGI
Operating Cash FlowLast quarter
$-35.3M
$-6.9M
Free Cash FlowOCF − Capex
$-7.0M
FCF MarginFCF / Revenue
-218.1%
Capex IntensityCapex / Revenue
4.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-10.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRD
IRD
MIGI
MIGI
Q4 25
$-35.3M
$-6.9M
Q3 25
$-6.2M
$-844.5K
Q2 25
$-10.3M
$-2.1M
Q1 25
$-9.0M
$-510.4K
Q4 24
$-25.6M
$3.6M
Q3 24
$-5.1M
$-1.2M
Q2 24
$-7.3M
$2.5M
Q1 24
$-5.7M
$1.9M
Free Cash Flow
IRD
IRD
MIGI
MIGI
Q4 25
$-7.0M
Q3 25
$-859.7K
Q2 25
$-2.1M
Q1 25
$-516.9K
Q4 24
$1.6M
Q3 24
$-1.3M
Q2 24
$592.4K
Q1 24
$1.9M
FCF Margin
IRD
IRD
MIGI
MIGI
Q4 25
-218.1%
Q3 25
-6.5%
Q2 25
-22.3%
Q1 25
-3.7%
Q4 24
10.7%
Q3 24
-10.4%
Q2 24
4.5%
Q1 24
9.9%
Capex Intensity
IRD
IRD
MIGI
MIGI
Q4 25
4.6%
Q3 25
0.1%
Q2 25
0.5%
Q1 25
0.0%
Q4 24
13.0%
Q3 24
0.3%
Q2 24
14.3%
Q1 24
0.1%
Cash Conversion
IRD
IRD
MIGI
MIGI
Q4 25
Q3 25
-2.58×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons